Skip to main content

Table 7 Statistical analysis of the results obtained using the proposed spectrofluorimetric and reported methods for analysis of the investigated drugs in pharmaceutical dosage forms

From: Spectrofluorimetric determination of certain antidepressant drugs in human plasma

Drug Pharmaceutical dosage forms Proposed method ± SD (n = 5) Reported methods 8-10 ± SD (n = 5)
Fluoxetine Neurazine® tablets 100.94 ± 1.390 100.53 ± 1.46
t = 0.45 e F = 1.09 e
Sertraline Thiozine® tablets 100.18 ± 1.15 100.13 ± 1.68
t = 0.06 F = 2.13
Paroxetine Stellasil® tablets 100.01 ± 1.196 99.98 ± 0.95
t = 0.04 F = 1.59
Thioridazine Tryptizol® tablets 100.62 ± 0.663 100.22 ± 1.07
t = 0.71 F = 2.59
Amineptine Survector® capsules 100.14 ± 1.26 99.88 ± 1.59
   t = 0.29 F = 1.59  
  1. eTabulated value at 95% confidence limit; F = 6.338 and t = 2.306.